Cavallo Ventures

Cavallo Ventures is the strategic venture capital arm of Wilbur-Ellis, a diversified international company with over a century of experience in agriculture, animal nutrition, and specialty chemicals and ingredients. Based in San Francisco, California, Cavallo Ventures focuses its investments on early-stage companies, typically from Seed to Series B, that are innovating across the animal nutrition, health, and technology sectors. Their specific areas of interest include feed, pet nutrition, aquafeed, ingredients, and advanced formulation, reflecting a deep commitment to the future of animal agriculture and pet care.

The firm leverages Wilbur-Ellis's extensive industry expertise, market access, and operational capabilities to provide significant strategic value to its portfolio companies beyond just capital. This corporate venture model allows Cavallo Ventures to identify and support disruptive technologies and business models that align with the parent company's long-term vision. They seek out companies that can drive efficiency, sustainability, and innovation within the global animal protein and pet industries, from precision nutrition solutions to novel ingredient development.

Cavallo Ventures manages two distinct funds, with Fund I and Fund II each capitalized at $100 million, bringing their total committed capital to $200 million. As of early 2024, their portfolio includes approximately 28 investments, showcasing a broad range of innovative companies. Their typical first check size ranges from $1 million to $5 million, indicating a preference for meaningful early-stage participation. This strategic investment approach positions Cavallo Ventures as a key player in fostering advancements within the critical and evolving animal health and nutrition value chain.